Randomized Trial of High Dose Chemotherapy With Autologous Bone Marrow Support as Adjuvant Therapy for High-Risk, Multi-Node Positive Malignant Melanoma

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

1988 • 384 citations

A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous Melanoma

1982 • 282 citations

Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes

1982 • 163 citations

Current therapy for malignant melanoma.

1989 • 127 citations

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

1989 • 114 citations

Prognosis of skin melanoma with regional node metastases (stage II)

1984 • 89 citations

Adjuvant Immunotherapy or Chemotherapy for Malignant Melanoma: Preliminary Report of the National Cancer Institute Randomized Clinical Trial

1981 • 79 citations

Prognostic Value of Lymph Node Dissection in Malignant Melanoma

1980 • 74 citations

Cutaneous Malignant Melanoma: Prognostic Guidelines for Physicians and Patients

1982 • 63 citations

Specific Active Immunotherapy for Melanoma

1979 • 58 citations

Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation

1983 • 55 citations

Adjuvant chemotherapy in the management of primary malignant melanoma

1978 • 46 citations

Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation.

1985 • 34 citations

Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma.

1984 • 28 citations

High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma

1989 • 28 citations

Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation Preliminary results—Phase I study

1982 • 23 citations